Shire PLC Rating Reiterated by Deutsche Bank (SHP)
Shire PLC (LON:SHP)‘s stock had its “buy” rating reaffirmed by Deutsche Bank in a research note issued on Tuesday. They currently have a GBX 3,920 ($65.94) target price on the stock. Deutsche Bank’s price objective indicates a potential upside of 17.75% from the company’s current price.
Shares of Shire PLC (LON:SHP) traded down 0.72% during mid-day trading on Tuesday, hitting GBX 3329.00. 1,057,471 shares of the company’s stock traded hands. Shire PLC has a 52 week low of GBX 1978.0001 and a 52 week high of GBX 4133.00. The stock has a 50-day moving average of GBX 3145.37 and a 200-day moving average of GBX 3021.. The company’s market cap is £19.451 billion.
SHP has been the subject of a number of other recent research reports. Analysts at Societe Generale reiterated a “buy” rating on shares of Shire PLC in a research note on Tuesday, May 13th. They now have a GBX 4,010 ($67.45) price target on the stock. Separately, analysts at Citigroup Inc. raised their price target on shares of Shire PLC from GBX 4,000 ($67.28) to GBX 4,100 ($68.97) in a research note on Friday, May 9th. They now have a “buy” rating on the stock. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Shire PLC in a research note on Thursday, May 1st. They now have a GBX 4,000 ($67.28) price target on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of GBX 2,841.61 ($47.80).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.